Famotidine
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171902This classification denotes a histamine-2 receptor antagonist with the molecular formula C8H15N7O2S3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5QZO15J2Z8, chemically known as propanimidamide, n-(aminosulfonyl)-3-(((2-((diaminomethylene)amino)-4-thiazoly)methyl)thio)- but generally known as famotidine, which bears US NIH Compound Identifier 3325. European Medicines Agency schedules Famotidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07503MIG. The term FAMOTIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 37, No. 6, 1983, List 23). World Health Organization schedules famotidine in its Anatomical Therapeutic Chemical (ATC) Classification. FAMOTIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule famotidine under HS 29341000 and SITC 51579. As of Q4 2014, FAMOTIDINE remains the US FDA Preferred Term for this commodity. Famotidine bears US NLM identifiers UMLS ID C0015620 and NCI Concept Code C29045. SMILES: S(CCC(=N\S(=O)(=O)N)\N)CC1NC(SC1)/N=C(/N)N.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.